Kelly Kral

Kelly Kral has a strong background in chemical engineering and has held various leadership roles in companies such as bluebird bio, Percivia, and Genzyme. Currently serving as the Vice President of CMC Strategy & Operations at bluebird bio, Kelly manages a team responsible for the development and execution of CMC strategies for gene therapy programs. With a focus on technical expertise and team management, Kelly has played a crucial role in the successful development and manufacturing of various biotech products throughout their career.